Walleye Capital’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-266,331
| Closed | -$2.33M | – | 2295 |
|
|
2025
Q1 | $2.33M | Sell |
266,331
-25,554
| -9% | -$223K | 0.01% | 556 |
|
|
2024
Q4 | $4.19M | Buy |
291,885
+281,975
| +2,845% | +$4.05M | 0.01% | 484 |
|
|
2024
Q3 | $224K | Sell |
9,910
-2,848
| -22% | -$64.3K | ﹤0.01% | 1648 |
|
|
2024
Q2 | $248K | Buy |
12,758
+6,119
| +92% | +$119K | ﹤0.01% | 1770 |
|
|
2024
Q1 | $249K | Buy |
+6,639
| New | +$249K | ﹤0.01% | 1721 |
|
|
2023
Q4 | – | Sell |
-17,220
| Closed | -$710K | – | 3008 |
|
|
2023
Q3 | $710K | Buy |
17,220
+15,873
| +1,178% | +$655K | ﹤0.01% | 1015 |
|
|
2023
Q2 | $75.2K | Buy |
+1,347
| New | +$75.2K | ﹤0.01% | 1514 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2728 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2620 |
|
|
2021
Q3 | – | Sell |
-3,516
| Closed | -$689 | – | 1794 |
|
|
2021
Q2 | $689 | Sell |
3,516
-1,202
| -25% | -$236 | 0.02% | 604 |
|
|
2021
Q1 | $854 | Sell |
4,718
-6,396
| -58% | -$1.16K | 0.05% | 351 |
|
|
2020
Q4 | $1.57K | Buy |
11,114
+2,230
| +25% | +$316 | 0.11% | 156 |
|
|
2020
Q3 | $1.11M | Buy |
8,884
+6,461
| +267% | +$806K | 0.12% | 210 |
|
|
2020
Q2 | $216K | Buy |
+2,423
| New | +$216K | 0.05% | 412 |
|